These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 16855686)

  • 1. Identification of a botulinum neurotoxin A protease inhibitor displaying efficacy in a cellular model.
    Boldt GE; Eubanks LM; Janda KD
    Chem Commun (Camb); 2006 Aug; (29):3063-5. PubMed ID: 16855686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.
    Burnett JC; Wang C; Nuss JE; Nguyen TL; Hermone AR; Schmidt JJ; Gussio R; Wipf P; Bavari S
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5811-3. PubMed ID: 19703771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A.
    Park JG; Sill PC; Makiyi EF; Garcia-Sosa AT; Millard CB; Schmidt JJ; Pang YP
    Bioorg Med Chem; 2006 Jan; 14(2):395-408. PubMed ID: 16203152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the protease activity of the light chain of type A botulinum neurotoxin by aqueous extract from stinging nettle (Urtica dioica) leaf.
    Gul N; Ahmed SA; Smith LA
    Basic Clin Pharmacol Toxicol; 2004 Nov; 95(5):215-9. PubMed ID: 15546475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the discovery of potent inhibitors of botulinum neurotoxin A: development of a robust LC MS based assay operational from low to subnanomolar enzyme concentrations.
    Capková K; Hixon MS; McAllister LA; Janda KD
    Chem Commun (Camb); 2008 Aug; (30):3525-7. PubMed ID: 18654701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin A: effects of zinc ion and peptides on inhibition.
    Lai H; Feng M; Roxas-Duncan V; Dakshanamurthy S; Smith LA; Yang DC
    Arch Biochem Biophys; 2009 Nov; 491(1-2):75-84. PubMed ID: 19772855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.
    Jacobson AR; Adler M; Silvaggi NR; Allen KN; Smith GM; Fredenburg RA; Stein RL; Park JB; Feng X; Shoemaker CB; Deshpande SS; Goodnough MC; Malizio CJ; Johnson EA; Pellett S; Tepp WH; Tzipori S
    Toxicon; 2017 Oct; 137():36-47. PubMed ID: 28698055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin B2-mediated cellular photoinhibition of botulinum neurotoxin A.
    Eubanks LM; Dickerson TJ; Janda KD
    FEBS Lett; 2005 Oct; 579(24):5361-4. PubMed ID: 16198354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease.
    Burnett JC; Opsenica D; Sriraghavan K; Panchal RG; Ruthel G; Hermone AR; Nguyen TL; Kenny TA; Lane DJ; McGrath CF; Schmidt JJ; Vennerstrom JL; Gussio R; Solaja BA; Bavari S
    J Med Chem; 2007 May; 50(9):2127-36. PubMed ID: 17417831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins.
    Capková K; Salzameda NT; Janda KD
    Toxicon; 2009 Oct; 54(5):575-82. PubMed ID: 19327377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic features of the botulinum neurotoxin A light chain revealed by high resolution structure of an inhibitory peptide complex.
    Silvaggi NR; Wilson D; Tzipori S; Allen KN
    Biochemistry; 2008 May; 47(21):5736-45. PubMed ID: 18457419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhodanine derivatives as selective protease inhibitors against bacterial toxins.
    Johnson SL; Chen LH; Harbach R; Sabet M; Savinov A; Cotton NJ; Strongin A; Guiney D; Pellecchia M
    Chem Biol Drug Des; 2008 Feb; 71(2):131-9. PubMed ID: 18221310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
    Brignole C; Marimpietri D; Pastorino F; Nico B; Di Paolo D; Cioni M; Piccardi F; Cilli M; Pezzolo A; Corrias MV; Pistoia V; Ribatti D; Pagnan G; Ponzoni M
    J Natl Cancer Inst; 2006 Aug; 98(16):1142-57. PubMed ID: 16912267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of lipid rafts enhances activity of botulinum neurotoxin serotype A.
    Petro KA; Dyer MA; Yowler BC; Schengrund CL
    Toxicon; 2006 Dec; 48(8):1035-45. PubMed ID: 17046039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental conditions substantially influence botulinum toxin potency testing.
    Mander G; Fink K; Vey M
    Clin Neuropharmacol; 2009; 32(4):234; author reply 235. PubMed ID: 19644233
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of purification on the bioavailability of botulinum neurotoxin type A.
    Cheng LW; Onisko B; Johnson EA; Reader JR; Griffey SM; Larson AE; Tepp WH; Stanker LH; Brandon DL; Carter JM
    Toxicology; 2008 Jul; 249(2-3):123-9. PubMed ID: 18538461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of botulinum neurotoxin-A activity in food by peptide cleavage assay.
    Rasooly R; Stanker LH; Carter JM; Do PM; Cheng LW; He X; Brandon DL
    Int J Food Microbiol; 2008 Aug; 126(1-2):135-9. PubMed ID: 18571757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-time PCR detection of the nontoxic nonhemagglutinin gene as a rapid screening method for bacterial isolates harboring the botulinum neurotoxin (A-G) gene complex.
    Raphael BH; Andreadis JD
    J Microbiol Methods; 2007 Dec; 71(3):343-6. PubMed ID: 17961766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Throughput Screening Uncovers Novel Botulinum Neurotoxin Inhibitor Chemotypes.
    Bompiani KM; Caglič D; Krutein MC; Benoni G; Hrones M; Lairson LL; Bian H; Smith GR; Dickerson TJ
    ACS Comb Sci; 2016 Aug; 18(8):461-74. PubMed ID: 27314875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against botulinum neurotoxin type A as a cause of treatment failure after the first detrusor injection.
    Schulte-Baukloh H; Bigalke H; Heine G; Pape D; Stuerzebecher B; Miller K; Knispel HH
    Urology; 2007 Mar; 69(3):575.e13-5. PubMed ID: 17382174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.